State-of-the-art computer- and robot-assisted surgery systems rely on intraoperative imaging technologies such as computed tomography and fluoroscopy to provide detailed 3D visualizations of patient anatomy. However, these methods expose both patients and clinicians to ionizing radiation. This study introduces a radiation-free approach for 3D spine reconstruction using RGB-D data. Inspired by the "mental map" surgeons form during procedures, we present SurgPointTransformer, a shape completion method that reconstructs unexposed spinal regions from sparse surface observations. The method begins with a vertebra segmentation step that extracts vertebra-level point clouds for subsequent shape completion. SurgPointTransformer then uses an attention mechanism to learn the relationship between visible surface features and the complete spine structure. The approach is evaluated on an <i>ex vivo</i> dataset comprising nine samples, with CT-derived data used as ground truth. SurgPointTransformer significantly outperforms state-of-the-art baselines, achieving a Chamfer distance of 5.39 mm, an F-score of 0.85, an Earth mover's distance of 11.00 and a signal-to-noise ratio of 22.90 dB. These results demonstrate the potential of our method to reconstruct 3D vertebral shapes without exposing patients to ionizing radiation. This work contributes to the advancement of computer-aided and robot-assisted surgery by enhancing system perception and intelligence.

Quantitative analysis of PET images in brain PET/CT relies on MRI-derived regions of interest (ROIs). However, the pairs of PET/CT and MR images are not always available, and their alignment is challenging if their acquisition times differ considerably. To address these problems, this study proposes a deep learning framework for translating CT of PET/CT to synthetic MR images (MR_SYN) and performing automated quantitative regional analysis using MR_SYN-derived segmentation. In this retrospective study, 139 subjects who underwent brain [¹⁸F]FBB PET/CT and T1-weighted MRI were included. A U-Net-like model was trained to translate CT images to MR_SYN; subsequently, a separate model was trained to segment MR_SYN into 95 regions. Regional and composite standardised uptake value ratio (SUVr) was calculated in [¹⁸F]FBB PET images using the acquired ROIs. For evaluation of MR_SYN, quantitative measurements including structural similarity index measure (SSIM) were employed, while for MR_SYN-based segmentation evaluation, Dice similarity coefficient (DSC) was calculated. Wilcoxon signed-rank test was performed for SUVrs computed using MR_SYN and ground-truth MR (MR_GT). Compared to MR_GT, the mean SSIM of MR_SYN was 0.974 ± 0.005. The MR_SYN-based segmentation achieved a mean DSC of 0.733 across 95 regions. No statistical significance (P > 0.05) was found for SUVr between the ROIs from MR_SYN and those from MR_GT, excluding the precuneus. We demonstrated a deep learning framework for automated regional brain analysis in PET/CT with MR_SYN. Our proposed framework can benefit patients who have difficulties in performing an MRI scan.

Magnetic resonance imaging (MRI) is a widely used radiological modality renowned for its radiation-free, comprehensive insights into the human body, facilitating medical diagnoses. However, the drawback of prolonged scan times hinders its accessibility. The k-space undersampling offers a solution, yet the resultant artifacts necessitate meticulous removal during image reconstruction. Although deep learning (DL) has proven effective for fast MRI image reconstruction, its broader applicability across various imaging scenarios has been constrained. Challenges include the high cost and privacy restrictions associated with acquiring large-scale, diverse training data, coupled with the inherent difficulty of addressing mismatches between training and target data in existing DL methodologies. Here, we present a novel Physics-Informed Synthetic data learning Framework for fast MRI, called PISF. PISF marks a breakthrough by enabling generalizable DL for multi-scenario MRI reconstruction through a single trained model. Our approach separates the reconstruction of a 2D image into many 1D basic problems, commencing with 1D data synthesis to facilitate generalization. We demonstrate that training DL models on synthetic data, coupled with enhanced learning techniques, yields in vivo MRI reconstructions comparable to or surpassing those of models trained on matched realistic datasets, reducing the reliance on real-world MRI data by up to 96 %. With a single trained model, our PISF supports the high-quality reconstruction under 4 sampling patterns, 5 anatomies, 6 contrasts, 5 vendors, and 7 centers, exhibiting remarkable generalizability. Its adaptability to 2 neuro and 2 cardiovascular patient populations has been validated through evaluations by 10 experienced medical professionals. In summary, PISF presents a feasible and cost-effective way to significantly boost the widespread adoption of DL in various fast MRI applications.

Steatotic liver disease (SLD) is the most common liver disease worldwide, affecting 30% of the global population. It is strongly associated with the interplay of genetic and lifestyle-related risk factors. The genetic variant accounting for the largest fraction of SLD heritability is PNPLA3 I148M, which is carried by 23% of the western population and increases the risk of SLD two to three-fold. However, identification of variant carriers is not part of routine clinical care and prevents patients from receiving personalised care. We analysed MRI images and common genetic variants in PNPLA3, TM6SF2, MTARC1, HSD17B13 and GCKR from a cohort of 45 603 individuals from the UK Biobank. Proton density fat fraction (PDFF) maps were generated using a water-fat separation toolbox, applied to the magnitude and phase MRI data. The liver region was segmented using a U-Net model trained on 600 manually segmented ground truth images. The resulting liver masks and PDFF maps were subsequently used to calculate liver PDFF values. Individuals with (PDFF ≥ 5%) and without SLD (PDFF < 5%) were selected as the study cohort and used to train and test a Vision Transformer classification model with five-fold cross validation. We aimed to differentiate individuals who are homozygous for the PNPLA3 I148M variant from non-carriers, as evaluated by the area under the receiver operating characteristic curve (AUROC). To ensure a clear genetic contrast, all heterozygous individuals were excluded. To interpret our model, we generated attention maps that highlight the regions that are most predictive of the outcomes. Homozygosity for the PNPLA3 I148M variant demonstrated the best predictive performance among five variants with AUROC of 0.68 (95% CI: 0.64-0.73) in SLD patients and 0.57 (95% CI: 0.52-0.61) in non-SLD patients. The AUROCs for the other SNPs ranged from 0.54 to 0.57 in SLD patients and from 0.52 to 0.54 in non-SLD patients. The predictive performance was generally higher in SLD patients compared to non-SLD patients. Attention maps for PNPLA3 I148M carriers showed that fat deposition in regions adjacent to the hepatic vessels, near the liver hilum, plays an important role in predicting the presence of the I148M variant. Our study marks novel progress in the non-invasive detection of homozygosity for PNPLA3 I148M through the application of deep learning models on MRI images. Our findings suggest that PNPLA3 I148M might affect the liver fat distribution and could be used to predict the presence of PNPLA3 variants in patients with fatty liver. The findings of this research have the potential to be integrated into standard clinical practice, particularly when combined with clinical and biochemical data from other modalities to increase accuracy, enabling easier identification of at-risk individuals and facilitating the development of tailored interventions for PNPLA3 I148M-associated liver disease.

The reliance on computationally intensive U-Net and Transformer architectures significantly limits their accessibility in low-resource environments, creating a technological divide that hinders global healthcare equity, especially in medical diagnostics and treatment planning. This divide is most pronounced in low- and middle-income countries, primary care facilities, and conflict zones. We introduced MED-NCA, Neural Cellular Automata (NCA) based segmentation models characterized by their low parameter count, robust performance, and inherent quality control mechanisms. These features drastically lower the barriers to high-quality medical image analysis in resource-constrained settings, allowing the models to run efficiently on hardware as minimal as a Raspberry Pi or a smartphone. Building upon the foundation laid by MED-NCA, this paper extends its validation across eight distinct anatomies, including the hippocampus and prostate (MRI, 3D), liver and spleen (CT, 3D), heart and lung (X-ray, 2D), breast tumor (Ultrasound, 2D), and skin lesion (Image, 2D). Our comprehensive evaluation demonstrates the broad applicability and effectiveness of MED-NCA in various medical imaging contexts, matching the performance of two magnitudes larger UNet models. Additionally, we introduce NCA-VIS, a visualization tool that gives insight into the inference process of MED-NCA and allows users to test its robustness by applying various artifacts. This combination of efficiency, broad applicability, and enhanced interpretability makes MED-NCA a transformative solution for medical image analysis, fostering greater global healthcare equity by making advanced diagnostics accessible in even the most resource-limited environments.

Low-dose computed tomography (LDCT) denoising plays an important role in medical imaging for reducing the radiation dose to patients. Recently, various data-driven and diffusion-based deep learning (DL) methods have been developed and shown promising results in LDCT denoising. However, challenges remain in ensuring generalizability to different datasets and mitigating uncertainty from stochastic sampling. In this paper, we introduce a novel dose-aware diffusion model that effectively reduces CT image noise while maintaining structural fidelity and being generalizable to different dose levels.&#xD;Approach: Our approach employs a physics-based forward process with continuous timesteps, enabling flexible representation of diverse noise levels. We incorporate a computationally efficient noise calibration module in our diffusion framework that resolves misalignment between intermediate results and their corresponding timesteps. Furthermore, we present a simple yet effective method for estimating appropriate timesteps for unseen LDCT images, allowing generalization to an unknown, arbitrary dose levels.&#xD;Main Results: Both qualitative and quantitative evaluation results on Mayo Clinic datasets show that the proposed method outperforms existing denoising methods in preserving the noise texture and restoring anatomical structures. The proposed method also shows consistent results on different dose levels and an unseen dataset.&#xD;Significance: We propose a novel dose-aware diffusion model for LDCT denoising, aiming to address the generalization and uncertainty issues of existing diffusion-based DL methods. Our experimental results demonstrate the effectiveness of the proposed method across different dose levels. We expect that our approach can provide a clinically practical solution for LDCT denoising with its high structural fidelity and computational efficiency.

Fetal cardiovascular magnetic resonance is an emerging tool for prenatal congenital heart disease assessment, but long acquisition times and fetal movements limit its clinical use. This study evaluates the clinical utility of deep learning super-resolution reconstructions for rapidly acquired, low-resolution fetal cardiovascular magnetic resonance. This prospective study included participants with fetal congenital heart disease undergoing fetal cardiovascular magnetic resonance in the third trimester of pregnancy, with axial cine images acquired at normal resolution and low resolution. Low-resolution cine data was subsequently reconstructed using a deep learning super-resolution framework (cine_DL). Acquisition times, apparent signal-to-noise ratio, contrast-to-noise ratio, and edge rise distance were assessed. Volumetry and functional analysis were performed. Qualitative image scores were rated on a 5-point Likert scale. Cardiovascular structures and pathological findings visible in cine_DL images only were assessed. Statistical analysis included the Student paired <i>t</i> test and the Wilcoxon test. A total of 42 participants were included (median gestational age, 35.9 weeks [interquartile range (IQR), 35.1-36.4]). Cine_DL acquisition was faster than cine images acquired at normal resolution (134±9.6 s versus 252±8.8 s; <i>P</i><0.001). Quantitative image quality metrics and image quality scores for cine_DL were higher or comparable with those of cine images acquired at normal-resolution images (eg, fetal motion, 4.0 [IQR, 4.0-5.0] versus 4.0 [IQR, 3.0-4.0]; <i>P</i><0.001). Nonpatient-related artifacts (eg, backfolding) were more pronounced in Cine_DL compared with cine images acquired at normal-resolution images (4.0 [IQR, 4.0-5.0] versus 5.0 [IQR, 3.0-4.0]; <i>P</i><0.001). Volumetry and functional results were comparable. Cine_DL revealed additional structures in 10 of 42 fetuses (24%) and additional pathologies in 5 of 42 fetuses (12%), including partial anomalous pulmonary venous connection. Deep learning super-resolution reconstructions of low-resolution acquisitions shorten acquisition times and achieve diagnostic quality comparable with standard images, while being less sensitive to fetal bulk movements, leading to additional diagnostic findings. Therefore, deep learning super-resolution may improve the clinical utility of fetal cardiovascular magnetic resonance for accurate prenatal assessment of congenital heart disease.

Recent innovations in vector flow imaging promise to bring the modality closer to clinical application and allow for more comprehensive high-frame-rate vascular assessments. One such innovation is plane-wave multi-angle vector Doppler, where pulsed Doppler principles from multiple steering angles are used to realize vector flow imaging at frame rates upward of 1,000 frames per second (fps). Currently, vector Doppler is limited by the presence of aliasing artifacts that have prevented its reliable realization at the bedside. In this work, we present a new aliasing-resistant vector Doppler imaging system that can be deployed at the bedside using a programmable ultrasound core, graphics processing unit (GPU) processing, and deep learning principles. The framework supports two operational modes: 1) live imaging at 17 fps where vector flow imaging serves to guide image view navigation in blood vessels with complex dynamics; 2) on-demand replay mode where flow data acquired at high frame rates of over 1,000 fps is depicted as a slow-motion playback at 60 fps using an aliasing-resistant vector projectile visualization. Using our new system, aliasing-free vector flow cineloops were successfully obtained in a stenosis phantom experiment and in human bifurcation imaging scans. This system represents a major engineering advance towards the clinical adoption of vector flow imaging.

Magnetic resonance spectroscopic imaging has potential for non-invasive metabolic imaging of the human brain. Here we report a method that overcomes several long-standing technical barriers associated with clinical magnetic resonance spectroscopic imaging, including long data acquisition times, limited spatial coverage and poor spatial resolution. Our method achieves ultrafast data acquisition using an efficient approach to encode spatial, spectral and J-coupling information of multiple molecules. Physics-informed machine learning is synergistically integrated in data processing to enable reconstruction of high-quality molecular maps. We validated the proposed method through phantom experiments. We obtained high-resolution molecular maps from healthy participants, revealing metabolic heterogeneities in different brain regions. We also obtained high-resolution whole-brain molecular maps in regular clinical settings, revealing metabolic alterations in tumours and multiple sclerosis. This method has the potential to transform clinical metabolic imaging and provide a long-desired capability for non-invasive label-free metabolic imaging of brain function and diseases for both research and clinical applications.

Computed tomography (CT) systems are indispensable for diagnostics but pose risks due to radiation exposure. Low-dose CT (LDCT) mitigates these risks but introduces noise and artifacts that compromise diagnostic accuracy. While deep learning methods, such as convolutional neural networks (CNNs) and generative adversarial networks (GANs), have been applied to LDCT denoising, challenges persist, including difficulties in preserving fine details and risks of model collapse. Recently, the Denoising Diffusion Probabilistic Model (DDPM) has addressed the limitations of traditional methods and demonstrated exceptional performance across various tasks. Despite these advancements, its high computational cost during training and extended sampling time significantly hinder practical clinical applications. Additionally, DDPM's reliance on random Gaussian noise can reduce optimization efficiency and performance in task-specific applications. To overcome these challenges, this study proposes a novel LDCT denoising framework that integrates the Latent Diffusion Model (LDM) with the Cold Diffusion Process. LDM reduces computational costs by conducting the diffusion process in a low-dimensional latent space while preserving critical image features. The Cold Diffusion Process replaces Gaussian noise with a CT denoising task-specific degradation approach, enabling efficient denoising with fewer time steps. Experimental results demonstrate that the proposed method outperforms DDPM in key metrics, including PSNR, SSIM, and RMSE, while achieving up to 2 × faster training and 14 × faster sampling. These advancements highlight the proposed framework's potential as an effective and practical solution for real-world clinical applications.